These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33491593)

  • 21. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
    Rudgard WE; Evans CA; Sweeney S; Wingfield T; Lönnroth K; Barreira D; Boccia D
    PLoS Med; 2017 Nov; 14(11):e1002418. PubMed ID: 29112693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
    Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
    PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa.
    Mpobela Agnarson A; Williams A; Kambili C; Mattson G; Metz L
    Expert Rev Anti Infect Ther; 2020 May; 18(5):475-483. PubMed ID: 32186925
    [No Abstract]   [Full Text] [Related]  

  • 24. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India.
    Sarin R; Vohra V; Singla N; Thomas B; Krishnan R; Muniyandi M
    Indian J Tuberc; 2019 Jan; 66(1):150-157. PubMed ID: 30797274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.
    Yang T; Chen T; Che Y; Chen Q; Bo D
    BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households.
    Fuady A; Houweling TA; Mansyur M; Richardus JH
    Acta Med Indones; 2018 Jan; 50(1):3-10. PubMed ID: 29686170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inequity in catastrophic costs among tuberculosis-affected households in China.
    Xu CH; Jeyashree K; Shewade HD; Xia YY; Wang LX; Liu Y; Zhang H; Wang L
    Infect Dis Poverty; 2019 Jun; 8(1):46. PubMed ID: 31215476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines.
    Florentino JL; Arao RML; Garfin AMC; Gaviola DMG; Tan CR; Yadav RP; Hiatt T; Morishita F; Siroka A; Yamanaka T; Nishikiori N
    PLoS One; 2022; 17(2):e0264689. PubMed ID: 35226705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
    van Rensburg C; Berhanu R; Hirasen K; Evans D; Rosen S; Long L
    PLoS One; 2019; 14(6):e0217820. PubMed ID: 31170207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
    Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E
    Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
    Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
    Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Ghana's National Health Insurance Scheme provide financial protection to tuberculosis patients and their households?
    Pedrazzoli D; Carter DJ; Borghi J; Laokri S; Boccia D; Houben RM
    Soc Sci Med; 2021 May; 277():113875. PubMed ID: 33848718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Tuberculosis With Household Catastrophic Expenditure in South India.
    Muniyandi M; Thomas BE; Karikalan N; Kannan T; Rajendran K; Saravanan B; Vohra V; Okorosobo T; Lönnroth K; Tripathy SP
    JAMA Netw Open; 2020 Feb; 3(2):e1920973. PubMed ID: 32049293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China: A cross-sectional study.
    Wang Y; McNeil EB; Huang Z; Chen L; Lu X; Wang C; Chen H; Chongsuvivatwong V
    Medicine (Baltimore); 2020 Jul; 99(28):e21023. PubMed ID: 32664107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India.
    Mullerpattan JB; Udwadia ZZ; Banka RA; Ganatra SR; Udwadia ZF
    Indian J Tuberc; 2019 Jan; 66(1):87-91. PubMed ID: 30797290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.
    Sweeney S; Gomez G; Kitson N; Sinha A; Yatskevich N; Staples S; Moodliar R; Motlhako S; Maloma M; Rassool M; Ngubane N; Ndlovu E; Nyang'wa BT
    BMJ Open; 2020 Oct; 10(10):e036599. PubMed ID: 33039989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and indirect patient costs of tuberculosis care in India.
    Chandra A; Kumar R; Kant S; Parthasarathy R; Krishnan A
    Trop Med Int Health; 2020 Jul; 25(7):803-812. PubMed ID: 32306481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.